Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

NCT03067688 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hyperlipidemia

Interventions

DRUG: Temisartan+Amlodipine+Rosuvastatin (Combination drug)
DRUG: Temisartan+Amlodipine
DRUG: Temisartan+Rosuvastatin

Sponsor

Yuhan Corporation